A new human prostate carcinoma cell line, 22Rv1

In Vitro Cellular and Developmental Biology - Animal

Volumn 35, Issue 7, 1999, Pages 403-409

  Sramkoski, R Michael ^a   Pretlow II, Thomas G ^a   Giaconia, Joseph M ^a   Pretlow, Theresa P ^a   Schwartz, Stuart ^a,b   Sy, Man Sun ^a   Marengo, Susan R ^a,b   Rhim, Johng S ^c   Zhang, Desheng ^a   Jacobberger, James W ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Androgen response; Cancer; Cell growth; EGF; Epithelial cell; TGF ; Xenograft

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; PROSTATE CARCINOMA; XENOGRAFT;

MUS MUSCULUS;

EID: 0032771030     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-999-0115-4     Document Type: Article

References (37)

1. Barranco, M. A.; Alcaraz, A.; Corral, J. M.; Sole, M.; Mallofre, C.; Llopis, J.; Rodriguez, A.; Ribal, M. J.; Alvarez-Vijande, R.; Carretero, P. Numeric alterations in chromosomes 7 and 8 detected by fluorescent in situ hybridization correlate with high-grade localized prostate cancer. Eur. Urol. 34:419-425; 1998.
2. Brolin, J.; Skoog, L.; Ekman, P. Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue. Prostate 20:281-295; 1992.
3. Chah, J. A.; Rhim, J. S. Current status of prostate cancer research: development of in vitro model systems. Int. J. Oncol. 5:1233-1242; 1994.
4. Cheng, L.; Sun, J.; Pretlow, T. G.; Culp, J.; Yang, N. S. CWR22 xenograft as an ex vivo human tumor model for prostate cancer gene therapy. J. Natl. Cancer Inst. 88:607-611; 1996.
5. Cui, J.; Deubler, D. A.; Rohr, L. R.; Zhu, X. L.; Maxwell, T. M.; Changus, J. E.; Brothman, A. R. Chromosome 7 abnormalities in prostate cancer detected by dual-color fluorescence in situ hybridization. Cancer Genet. Cytogenet. 107:51-60; 1998.
6. Culig, Z.; Klocker, H.; Eberle, J.; Kaspar, F.; Hobisch, A.; Cronauer, M. V.; Bartsch, G. DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction. Prostate 22:11-22; 1993.
7. Ellis, W. J.; Vessella, R. L.; Buhler, K. R.; Bladou, F.; True, L. D.; Bigler, S. A.; Curtis, D.; Lange, P. H. Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23. Clin. Cancer Res. 2:1039-1048; 1996.
8. Gingrich, J. R.; Tucker, J. A.; Walther, P. J.; Day, J. W.; Poulton, S. H.; Webb, K. S. Establishment and characterization of a new human prostatic carcinoma cell line (DuPro-1). J. Urol. 146:915-919; 1991.
9. Gleave, M.; Hsieh, J. T.; Gao, C. A.; von Eschenbach, A. C.; Chung, L. W. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res. 51:3753-3761; 1991.
10. Grasso, A. W.; Wen, D.; Miller, C. M.; Rhim, J. S.; Pretlow, T. G.; Kung, H. J. ErbB kinases and NDF signaling in human prostate cancer cells. Oncogene 15:2705-2716; 1997.
11. Guo, Y.; Kyprianou, N. Overexpression of transforming growth factor (TGF) beta 1 type II receptor restores TGF-beta 1 sensitivity and signaling in human prostate cancer cells. Cell Growth Differ. 9:185-193; 1998.
12. Guo, Y.; Wu, Y.; Shinde, S.; Sy, M. S.; Aruffo, A.; Liu, Y. Identification of a costimulatory molecule rapidly induced by CD40L as CD44H. J. Exp. Med. 184:955-961; 1996.
13. Horoszewicz, J. S.; Leong, S. S.; Kawinski, E.; Karr, J. P.; Rosenthal, H.; Chu, T. M.; Mirand, E. A.; Murphy, G. P. LNCaP model of human prostatic carcinoma. Cancer Res. 43:1809-1818; 1983.
14. Iizumi, T.; Yazaki, T.; Kanoh, S.; Kondo, I.; Koiso, K. Establishment of a new prostatic carcinoma cell line (TSU-Pr1). J. Urol. 137:1304-1306; 1987.
15. Jenkins, R. B.; Qian, J.; Lee, H. K.; Huang, H.; Hirasawa, K.; Bostwrick, D. G.; Proffitt, J.; Wilber, K.; Lieber, M. M.; Liu, W., et al. A molecular cytogenetic analysis of 7q31 in prostate cancer. Cancer Res. 58:759-766; 1998.
16. Kaighn, M. E.; Narayan, K. S.; Ohnuki, Y.; Lechner, J. F.; Jones, L. W. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest. Urol. 17:16-23; 1979.
17. Katsuoka, Y.; Hoshino, H.; Shiramizu, M.; Sakabe, K.; Seiki, K. Autoradiographic and cytochemical localization of androgen in human prostatic cancer cell lines. Urology 28:228-231; 1986.
18. Lee, M. S.; Gakovenko, E.; Yun, J. S.; Weijerman, P. C.; Peehl, D. M.; Chen, L. S.; Rhim, J. S. Characterization of adult human prostatic cells immortalized by polybrene-induced DNA transfection with a plasmid containing an origin-defective SV40 genome. Int. J. Oncol. 821-830; 1994.
19. Marengo, S. R.; Resnick, M. I.; Yang, L.; Chung, J. Y. Differential expression of urinary inter-alpha-trypsin inhibitor trimers and dimers in normal compared to active calcium oxalate stone forming men [see comments]. J. Urol. 159:1444-1450; 1998.
20. Matturri, L.; Biondo, B.; Cazzullo, A.; Montanari, E.; Radice, F.; Timossi, R.; Turconi, P.; Lavezzi, A. M. Detection of trisomy 7 with fluorescence in situ hybridization and its correlation with DNA content and proliferating cell nuclear antigen-positivity in prostate cancer. Am. J. Clin. Oncol. 21:253-257; 1998.
21. Mickey, D. D.; Stone, K. R.; Wunderli, H.; Mickey, G. H.; Vollmer, R. T.; Paulson, D. F. Heterotransplanlation of a human prostatic adenocarcinoma cell line in nude mice. Cancer Res. 37:4049-4058; 1977.
22. Muraki, J.; Addonizio, J. C.; Choudhury, M. S.; Fischer, J.; Eshghi, M.; Davidian, M. M.; Shapiro, L. R.; Wilmot, P. L.; Nagamatsu, G. R.; Chiao, J. W. Establishment of new human prostatic cancer cell line (JCA-1). Urology 36:79-84; 1990.
23. Nagabhushan, M.; Miller, C. M.; Pretlow, T. P.; Giaconia, J. M.; Edgehouse, N. L.; Schwartz, S.; Kung, H. J.; de Vere While, R. W.; Gumerlook, P. H.; Kesnick, M. I., et al. CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Research 56:3042-3046; 1996.
24. Nagabhushan, M.; Pretlow, T. G.; Guo, V. J.; Amini, S. B.; Pretlow, T. P.; Sy, M. S. Altered expression of CD44 in human prostate cancer during progression. Am. J. Clin. Pathol. 106:647-651; 1996.
25. Narayan, P.; Dahiya, R. Establishment and characterization of a human primary prostatic adenocarcinoma cell line (ND-1). J. Urol. 148:1600-1604; 1992.
26. Pousette, A.; Carlstrom, K.; Henriksson, P.; Grande, M.; Stege, R. Use of a hormone-sensitive (LNCaP) and a hormone-resistant (LNCaP-r) cell line in prostate cancer research. Prostate 31:198-203; 1997.
27. Pretlow, T. G.; Delmoro, C. M.; Dilley, G. G.; Spadafora, C. G.; Pretlow, T. P. Transplantation of human prostatic carcinoma into nude mice in Matrigel. Cancer Res. 51:3814-3817; 1991.
28. Pretlow, T. G.; Wolman, S. R.; Micale, M. A.; Pelley, R. J.; Kursh, K. D.; Resnick, M. I.; Bodner, D. R.; Jacobberger, J. W.; Delmoro, C. M.; Giaconia, J. M., et al. Xenografts of primary human prostatic carcinoma. J. Natl. Cancer Inst. 85:394-398; 1993.
29. Schimenti, K. J.; Jacobberger, J. W. Fixation of mammalian cells for flow cytometric evaluation of DNA content and unclear immunofluorescence. Cytometry 13:48-59; 1992.
30. Seabright, M. A rapid banding technique for human chromosomes. Lancet 2:971-972; 1971.
31. Sica, G.; Fabbroni, L.; Dell'Acqua, G.; Iacopino, F.; Marchetti, P.; Cacciatore, M.; Pavone-Macaluso, M. Natural beta-interferon and androgen receptors in prostatic cancer cells. Urol. Int. 46:159-162; 1991.
32. Stevens, J. W.; Palechek, P. L.; Griebling, T. L.; Midura, R. J.; Rokhlin, O. W.; Cohen, M. B. Expression of CD44 isoforms in human prostate tumor cell lines [see comments]. Prostate 28:153-161; 1996.
33. Stone, K. R.; Mickey, D. D.; Wunderli, H.; Mickey, G. H.; Paulson, D. F. Isolation of a human prostate carcinoma cell line (DU 145). Int. J. Cancer 21:274-281; 1978.
34. Stubbs, A. P.; Lalani, E. N.; Stamp, G. W.; Hurst, H.; Abel, P.; Waxman, J. Second messenger up-regulation of androgen receptor gene transcription is absent in androgen insensitive human prostatic carcinoma cell lines. PC-3 and DU-145. FEBS Lett. 383:237-240; 1996.
35. Tan, J.; Sharief, Y.; Hamil, K. G.; Gregory, C. W.; Zang, D. Y.; Sar, M.; Gumerlock, P. H.; deVere White, R. W.; Pretlow, T. G.; Harris, S. E., et al. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells. Mol. Endocrinol. 11:450-459; 1997.
36. Tilley, W. D.; Wilson, C. M.; Marcelli, M.; McPhaul, M. J. Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Mes. 50:5382-5386; 1990.
37. Wainstein, M. A.; He, F.; Robinson, D.; Kung, H. J.; Schwartz, S.; Giaconia, J. M.; Edgehouse, N. L.; Pretlow, T. P.; Bodner, D. R.; Kursh, E. D., et al. CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma. Cancer Res. 54:6049-6052; 1994.